股骨原发未分化多形性肉瘤保肢治疗短期疗效观察
DOI:
作者:
作者单位:

西安交通大学医学院附属红会医院骨病肿瘤科

作者简介:

通讯作者:

中图分类号:

基金项目:


Observation of short-term efficacy of limb salvage treatment for femur primary undifferentiated pleomorphic sarcoma
Author:
Affiliation:

1.Department of Orthopaedic Oncology, Honghui Hospital, Medical College, Xi’an Jiaotong University;2.Department of Orthopaedic Oncology, Honghui Hospital, Medical College, Xi’an Jiaotong Universit

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘要:[目的] 采用手术联合化疗方法治疗患者股骨原发未分化多形性肉瘤,观察患者保肢治疗后短期临床疗效。[方法] 回顾性分析我科2015年10月至2019年10月病理诊断为下肢股骨未分化多形性肉瘤的10例患者临床资料。男3例、女7例,发病年龄16~73岁、平均(47.12±14.91)岁。所有患者术前行原发部位X线片、CT 和MRI检查,肺部CT及全身骨扫描检查,穿刺活检10例。Enneking外科分期:IIA期1例,IIB期9例(其中3例病理性骨折)。术前接受新辅助化疗者4例(洛铂+阿霉素+异环磷酰胺),术后接受化疗者8例(洛铂+阿霉素+异环磷酰胺)。接受肿瘤髋关节重建1例,接受节段型假体重建1例,接受肿瘤膝关节重建8例。依据国际骨与软组织肿瘤协会 ( MSTS ) 评分系统评价术后功能情况。[结果] 本组10例患者均获得随访7-43个月,平均(25.10±11.25)个月。4例死亡,全部为IIB期4例(2例病理性骨折),1例带瘤存活,5例无瘤存活。5例术后出现了肺转移或者其它部位多发转移,肿瘤转移平均时间(4.40±1.14)个月,2例局部复发。术后3个月下肢MSTS评分平均(26.5±1.58)分:1例患者接受肿瘤髋关节重建,28分;1例患者接受节段性假体重建29分;8例患者接受肿瘤膝关节重建平均(26.0±1.31)分。[结论] 保肢治疗是下肢股骨未分化多形性肉瘤的主要方法,广范边界手术切除和化疗能够获得疾病局部控制和长期生存,病理性骨折及化疗不敏感患者术后复发及转移可能性较大。保肢治疗下肢功能恢复满意。

    Abstract:

    Abstract: [Objective] Using surgery combined with chemotherapy to treat patients with primary undifferentiated pleomorphic sarcoma of the femur, to observe the short-term clinical efficacy of patients after limb salvage treatment. [Methods] The clinical data of 10 patients with undifferentiated pleomorphic sarcoma of the femur of the lower extremity diagnosed pathologically from October 2015 to October 2019 in our department were retrospectively analyzed. There were 3 males and 7 females. The age of onset was 16-73 years old, with an average of (47.12±14.91) years old. All patients underwent X-rays, CT and MRI examinations of the primary site, CT scans of the lungs and whole body bone scans, and 10 needle biopsies. Enneking surgical staging: 1 case in stage IIA, 9 cases in stage IIB (including 3 cases of pathological fractures). 4 patients received neoadjuvant chemotherapy (lobaplatin + adriamycin + ifosfamide) before surgery, and 8 patients received chemotherapy (lobaplatin + adriamycin + ifosfamide) after surgery. 1 case received tumor hip reconstruction, 1 case received segmental prosthesis reconstruction, and 8 cases received tumor knee joint reconstruction. According to the International Bone and Soft Tissue Tumor Society (MSTS) scoring system, the postoperative function was evaluated. [Results] All 10 patients in this group were followed up for 7-43 months, with an average of (25.10±11.25) months. 4 cases died, all of them were stage IIB 4 cases (2 cases of pathological fractures), 1 case survived with tumor, and 5 cases survived without tumor. Five cases had lung metastasis or multiple metastases in other parts after operation, the average time of tumor metastasis was (4.40±1.14) months, and 2 cases had local recurrence. The average MSTS score of lower extremities (26.5±1.58) at 3 months after surgery: 1 patient received tumor hip reconstruction, 28 points; 1 patient received segmental prosthesis reconstruction, 29 points; 8 patients received tumor knee reconstruction on average (26.0±1.31) points. [Conclusion] Limb salvage treatment is the main method for undifferentiated pleomorphic sarcoma of the femur of the lower extremity. Wide-range surgical resection and chemotherapy can achieve local disease control and long-term survival, and the possibility of postoperative recurrence and metastasis in patients with pathological fractures and chemotherapy insensitivity Larger. The limb salvage treatment has recovered satisfactory lower limb function.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-03-15
  • 最后修改日期:2021-06-15
  • 录用日期:2021-07-05
  • 在线发布日期:
  • 出版日期: